Biogen Idec (BIIB)

$217.51 4.00 (1.87%)

16:00 EDT BIIB Stock Quote Delayed 30 Minutes

7 Retirement Stocks to Buy at a 52-Week Low in April

By Ian Cooper, InvestorPlace Contributor Apr 29, 2024

One of the best ways to keep your portfolio safe while generating income is with dividend-paying retirement stocks at 52-week lows.

BIIB Stock Earnings: Biogen Beats EPS, Misses Revenue for Q1 2024

Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits

From Zero to Hero: 7 Stock Losers That Could Turn Things Around in 2024

Volume:

Previous Close -

Market Cap 31.32B

PE Ratio 34.53

EPS 6.3

Volume (Avg. Vol.) 1.14M

Day's Range $213.11 - $217.88

52-Week Range $189.44 - $319.76

Dividend & Yield N/A (N/A)

BIIB Stock Predictions, Articles, and Biogen Idec News

From InvestorPlace
From the Web

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness

By Josh Enomoto, InvestorPlace Contributor Feb 15, 2024

Last October, life sciences giant Thermo Fisher Scientific (NYSE:TMO) inadvertently laid out the case for contrarian biotech stocks. According to Reuters, the company revealed that…

7 Biotech Stocks Fighting America’s Deadliest Diseases

By Josh Enomoto, InvestorPlace Contributor Feb 8, 2024

Unlike many other market segments, biotech stocks stand out for their direct relevance. For example, investors who typically wager on aerospace and defense plays usually…

Time to Load Up on This New Magnificent 7 of ‘Strong Buy’ Stocks

By Paul R. La Monica, InvestorPlace Contributor Jan 12, 2024

Ring in the new year with these strong buy stocks that analysts love. They could form the next Magnificent 7 winners!

Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness

By Muslim Farooque, InvestorPlace Contributor Dec 27, 2023

Discover these innovative healthcare stocks, backed by the U.S.'s $4.3 trillion health investment, offering stability and high returns.

Top 3 Healthcare Stock Picks for the New Year

By Charles Munyi, InvestorPlace Contributor Dec 25, 2023

Buy these healthcare stocks for 2024 trading at bargain prices before their earnings inflect higher on improving fundamentals.

Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential

By Rick Orford, InvestorPlace Contributor Dec 14, 2023

The increased understanding and widespread acceptance of mental health concerns have put psychedelic stocks in the spotlight.

7 Low-Volatility Stocks to Buy if You’re a Concerned Investor

By Josh Enomoto, InvestorPlace Contributor Oct 11, 2023

With market and economic conditions worrying many investors, it may be time to consider the virtues of low-volatility stocks.

7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth

By Louis Navellier and the InvestorPlace Research Staff Sep 7, 2023

Pharma stocks can be a great investment, particularly if they have solid performance, revenue growth and a positive outlook.

3 ‘Strong Buy’ Biotech Stocks You Should Be Loading Up On Now

By Jeremy Flint, InvestorPlace Contributor Aug 2, 2023

Biotech stocks can be a lucrative investment opportunity, these three biotech stocks to buy now are among analyst favorites.

Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points

By Joel Baglole, InvestorPlace Contributor Aug 1, 2023

Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now.

Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil

By John Blankenhorn, InvestorPlace Contributor Jul 29, 2023

There is opportunity in a crisis. Key biotech stocks amid turmoil could be the greatest deals on the market today.

Why Is Reata Pharmaceuticals (RETA) Stock Up 53% Today?

By William White, InvestorPlace Writer Jul 28, 2023

Reata Pharmaceuticals (RETA) stock is soaring higher on Friday as investors react to an acquisition deal with Biogen (BIIB).

Biogen Layoffs 2023: What to Know About the Latest BIIB Job Cuts

By William White, InvestorPlace Writer Jul 25, 2023

Biogen (BIIB) layoffs are on the way as the company seeks further profits with its upcoming Alzheimer's disease drug launch.

BIIB Stock Alert: What to Know as FDA Approves Biogen’s Alzheimer’s Drug

By William White, InvestorPlace Writer Jul 7, 2023

Biogen (BIIB) stock is in the news Friday after the pharmaceutical company got approval from the FDA for its Alzheimer's drug.

How to Retire Rich: Biotech Stocks Edition

By Josh Enomoto, InvestorPlace Contributor Jun 18, 2023

Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.

7 Undervalued S&P 500 Stocks to Buy in June

By Josh Enomoto, InvestorPlace Contributor Jun 15, 2023

If you want to maximize your upside potential in a relatively predictable arena, these undervalued S&P 500 stocks could be for you.

BIIB Stock Alert: Biogen Resumes Trading With New FDA Backing

By William White, InvestorPlace Writer Jun 12, 2023

Biogen (BIIB) stock is a hot topic among traders Monday as the company's share resumed trading following a halt that was in effect on Friday.

3 Biotech Stocks That Are Revolutionizing Healthcare in 2023

By Chris Markoch, InvestorPlace Contributor May 19, 2023

Here are three of the best biotech stocks to buy; each is on the verge of significant breakthroughs that may send the price higher

The 3 Most Promising Biotech Innovations in 2023 and the Stocks to Buy

By Chris Markoch, InvestorPlace Contributor Apr 28, 2023

Here are three biotech companies with promising innovations that could provide catalysts for their respective stocks in 2023

7 Blue-Chip Stocks Sitting in the Sweet Spot

By Josh Enomoto, InvestorPlace Contributor Mar 23, 2023

Although blue-chip stocks carry a reputation for being bulky and not exciting, these large enterprises can really move.

Biogen Idec (BIIB)

7 Retirement Stocks to Buy at a 52-Week Low in April

BIIB Stock Earnings: Biogen Beats EPS, Misses Revenue for Q1 2024

Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits

From Zero to Hero: 7 Stock Losers That Could Turn Things Around in 2024

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Biogen Idec (BIIB)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

BIIB Stock Predictions, Articles, and Biogen Idec News

Subscriber Sign in